Biokem

Biokem is a biotechnology company that specializes in the development and commercialization of biopharmaceutical products. Founded in 2005, the company is headquartered in San Diego, California, and operates globally. Biokem's primary focus is on the discovery, development, and manufacturing of biologic drugs, which are therapeutic proteins and other biologically active molecules. These products are designed to treat a wide range of diseases, including cancer, autoimmune disorders, and infectious diseases.

The company's portfolio includes a variety of biologic drugs, such as monoclonal antibodies, cytokines, and fusion proteins. Biokem's research and development efforts are driven by its commitment to innovation and the advancement of personalized medicine. The company collaborates with academic institutions, research organizations, and pharmaceutical partners to accelerate the pace of drug discovery and development.

Biokem's manufacturing capabilities are state-of-the-art, adhering to stringent quality control standards to ensure the safety and efficacy of its products. The company's facilities are equipped with advanced bioprocessing technologies, enabling the production of high-quality biologic drugs on a large scale.

Biokem is dedicated to improving patient outcomes through its innovative biologic drugs. The company's mission is to deliver transformative therapies that address unmet medical needs and enhance the quality of life for patients worldwide. By leveraging its expertise in biotechnology, Biokem continues to push the boundaries of medical science and contribute to the advancement of healthcare.